scholarly article | Q13442814 |
P356 | DOI | 10.1021/JM0606138 |
P698 | PubMed publication ID | 17064073 |
P2093 | author name string | Christine Lukacs | |
Nan Jiang | |||
Kathryn Packman | |||
Allen Lovey | |||
Xuefeng Yin | |||
Nader Fotouhi | |||
Melissa A Smith | |||
Sung-Sau So | |||
Qing Xiang | |||
Yingsi Chen | |||
Petra Goelzer | |||
Ka Wang | |||
Bradford Graves | |||
David Bartkovitz | |||
Qingjie Ding | |||
Xin-Jie Chu | |||
Binh T Vu | |||
Wanda DePinto | |||
Gerald Kaplan | |||
John Moliterni | |||
Brian X Higgins | |||
P433 | issue | 22 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 6549-6560 | |
P577 | publication date | 2006-11-01 | |
P1433 | published in | Journal of Medicinal Chemistry | Q900316 |
P1476 | title | Discovery of [4-Amino-2-(1-methanesulfonylpiperidin-4-ylamino)pyrimidin-5-yl](2,3-difluoro-6- methoxyphenyl)methanone (R547), a potent and selective cyclin-dependent kinase inhibitor with significant in vivo antitumor activity | |
P478 | volume | 49 |